This multicenter large‐scale retrospective study on serum DCP assessed its clinical performance as a diagnostic and therapeutic marker of HCC and identified liver function as a remarkable factor that influences the specificity of serum DCP in the diagnosis of HCC. This evidence concerns the gene ACE and hepatocellular carcinoma.